WO2008126517A1 - 哺乳動物における新規slc17型トランスポータータンパク質およびその利用 - Google Patents
哺乳動物における新規slc17型トランスポータータンパク質およびその利用 Download PDFInfo
- Publication number
- WO2008126517A1 WO2008126517A1 PCT/JP2008/053878 JP2008053878W WO2008126517A1 WO 2008126517 A1 WO2008126517 A1 WO 2008126517A1 JP 2008053878 W JP2008053878 W JP 2008053878W WO 2008126517 A1 WO2008126517 A1 WO 2008126517A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- slc17
- mammal
- novel
- transporter protein
- type transporter
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/22—Haematology
- G01N2800/224—Haemostasis or coagulation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2842—Pain, e.g. neuropathic pain, psychogenic pain
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Abstract
ATP輸送を担うトランスポーターおよびそれをコードする遺伝子を単離することを本発明の課題とする。さらに、そのようなトランスポーターを用いる、中枢神経における疼痛や血小板由来のATPによる血液凝固などを処置および/または調節するための薬剤のスクリーニング法を提供することを、本発明の課題とする。本発明に従って、ATP輸送を担うトランスポーターおよびそれをコードする遺伝子が単離された。さらに、そのようなトランスポーターを用いる、中枢神経における疼痛や血小板由来のATPによる血液凝固などを処置および/または調節するための薬剤のスクリーニング法が提供される。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/594,149 US7951595B2 (en) | 2007-03-30 | 2008-03-04 | Methods for screening modulators of SLC17-type anion transport activity |
EP08721298A EP2159281B1 (en) | 2007-03-30 | 2008-03-04 | Novel slc17-type transporter protein in mammal and use thereof |
JP2008526701A JP5219146B2 (ja) | 2007-03-30 | 2008-03-04 | 哺乳動物における新規slc17型トランスポータータンパク質およびその利用 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007095055 | 2007-03-30 | ||
JP2007-095055 | 2007-03-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008126517A1 true WO2008126517A1 (ja) | 2008-10-23 |
Family
ID=39863675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/053878 WO2008126517A1 (ja) | 2007-03-30 | 2008-03-04 | 哺乳動物における新規slc17型トランスポータータンパク質およびその利用 |
Country Status (4)
Country | Link |
---|---|
US (1) | US7951595B2 (ja) |
EP (1) | EP2159281B1 (ja) |
JP (1) | JP5219146B2 (ja) |
WO (1) | WO2008126517A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017126700A1 (ja) * | 2016-01-20 | 2017-07-27 | 芳則 森山 | 小胞型ヌクレオチドトランスポーター活性阻害剤 |
CN116803424A (zh) * | 2023-08-24 | 2023-09-26 | 上海懿贝瑞生物医药科技有限公司 | Slc17a5基因抑制剂及其用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001066744A2 (en) * | 2000-03-06 | 2001-09-13 | Lexicon Genetics Incorporated | Human transporter proteins and polynucleotides encoding the same |
WO2001075164A2 (en) * | 2000-03-30 | 2001-10-11 | Whitehead Institute For Biomedical Research | Rna sequence-specific mediators of rna interference |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6420544B1 (en) * | 1999-05-19 | 2002-07-16 | Smithkline Beecham Corporation | Polynucleotide and polypeptide sequences encoding murine organic anion transporter 5 (mOATP5) |
US20060035315A1 (en) * | 2000-02-25 | 2006-02-16 | Incyte Genomics, Inc. | Transporters and ion channels |
US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
US6972187B2 (en) * | 2000-05-12 | 2005-12-06 | Millennium Pharmaceuticals, Inc. | OAT5 molecules and uses therefor |
US6783969B1 (en) * | 2001-03-05 | 2004-08-31 | Nuvelo, Inc. | Cathepsin V-like polypeptides |
-
2008
- 2008-03-04 WO PCT/JP2008/053878 patent/WO2008126517A1/ja active Application Filing
- 2008-03-04 EP EP08721298A patent/EP2159281B1/en not_active Not-in-force
- 2008-03-04 US US12/594,149 patent/US7951595B2/en not_active Expired - Fee Related
- 2008-03-04 JP JP2008526701A patent/JP5219146B2/ja not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001066744A2 (en) * | 2000-03-06 | 2001-09-13 | Lexicon Genetics Incorporated | Human transporter proteins and polynucleotides encoding the same |
WO2001075164A2 (en) * | 2000-03-30 | 2001-10-11 | Whitehead Institute For Biomedical Research | Rna sequence-specific mediators of rna interference |
Non-Patent Citations (58)
Title |
---|
"DNA Cloning 1: Core Techniques, A practical Approach", 1995, OXFORD UNIVERSITY PRESS |
"Experimental Methods in Transfection & Expression Analysis", 1997, YODOSHA |
"Matrices for Detecting Distance Relationships: Atlas of Protein Sequence and Structure", 1978, NATIONAL BIOMEDICAL RESEARCH FOUNDATION |
"Molecular Cloning", article "Current Protocols in Molecular Biology" |
"Vectors: A Survey of Molecular Cloning Vectors and Their Uses", 1988 |
ADAMS, R.L. ET AL.: "Biochemistry of the Nucleic Acids", 1992, CHAPMAN & HALL |
ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 410 |
ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, no. 3, 1990, pages 403 - 410 |
ALTSCHUL ET AL., NATURE GENETICS, vol. 3, 1993, pages 266 - 272 |
ALTSCHUL ET AL., NUC. ACIDS RES., vol. 25, 1997, pages 3389 - 3402 |
ANDERSON ET AL.: "Nucleic Acid Hybridization: A practical Approach", IRL PRESS LIMITED |
ANDERSON ET AL.: "Nucleic Acid Hybridization: A Practical Approach", vol. IV, IRL PRESS LIMITED |
AUSUBEL F.A. ET AL.: "Current Protocols in Molecular Biology", 1998, WILEY |
AUSUBEL, F.M.: "Current Protocols in Molecular Biology", 1987, GREENE PUB. ASSOCIATES AND WILEY- INTERSCIENCE |
AUSUBEL, F.M.: "Molecular Biology", 1999, WILEY, AND ANNUAL UPDATES, article "Short Protocols in Molecular Biology: A Compendium of Methods from Current Protocols" |
AUSUBEL, F.M.: "Short Protocols in Molecular Biology: A Compendium of Methods from Current Protocols in Molecular Biology", 1989, GREENE PUB. ASSOCIATES AND WILEY-INTERSCIENCE |
AUSUBEL, F.M.: "Short Protocols in Molecular Biology: A Compendium of Methods from Current Protocols in Molecular Biology", 1995, GREENE PUB. ASSOCIATES |
AUSUBEL: "Short Protocols in Molecular Biology: A Compendium of Methods from Current Protocols in Molecular Biology", 1992, GREENE PUB. ASSOCIATES |
BANKSTON LA; GUIDOTTI G., J. BIOL. CHEM., vol. 271, 1996, pages 17132 - 17138 |
BLACKBURN, G.M. ET AL.: "Nucleic Acids in Chemistry and Biology", 1996, OXFORD UNIVERSITY PRESS |
BURNSTOCK G., TIPS, vol. 27, 2006, pages 166 - 176 |
COCO S ET AL., J BIOL. CHEM., vol. 278, 2003, pages 1354 - 1362 |
ECKSTEIN, F.: "Oligonucleotides and Analogues: A Practical Approach", 1991, IRL PRESS |
ELBASHIR S.M. ET AL.: "Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells", NATURE, vol. 411, 2001, pages 494 - 498, XP001167187 * |
ELBASHIR S.M. ET AL.: "RNA interference is mediated by 21- and 22-nucleotide RNAs", GENES AND DEVELOPMENT, vol. 15, 2001, pages 188 - 200, XP002204651 * |
ENOSAWA S.: "III. Nano Seikagakukei ni yoru Hisaibosei Taisha Kino Daigae Device no Kaihatsu Kenkyu Sochika e Muketa Kakushu Sozai Oyobi Kiban Gijutsu no Togo, Nanotechnology ni yoru Kinoteki. Kozoteki Seitai Daigae Device no Kaihatsu", HEISEI 15 NENDO SOKATSU.BUNTAN KENKYU HOKOKUSHO, 2004, pages 151 - 164 * |
GAIT, M.J.: "Oligonucleotide Synthesis: A Practical Approach", 1985, IRL PRESS |
GAIT, M.J.: "Oligonucleotide Synthesis: A Practical Approach", 1990, IRL PRESS |
GONNET ET AL., CIENCE, vol. 256, 1992, pages 1443 - 1445 |
HENIKOFF; HENIKOFF, PROTEINS, vol. 17, 1993, pages 49 - 61 |
HERMANSON, G.T.: "Bioconjugate Techniques", 1996, ACADEMIC PRESS |
HIGGINS ET AL., METHODS ENZYMOL., vol. 266, 1996, pages 383 - 402 |
INNIS, M.A. ET AL.: "PCR Strategies", 1995, ACADEMIC PRESS |
INNIS, M.A.: "PCR Protocols: A Guide to Methods and Applications", 1990, ACADEMIC PRESS |
JUGE N ET AL., J. BIOL. CHEM., vol. 281, 2006, pages 39499 - 39506 |
JUGE N. ET AL.: "Vesicular glutamate transporter contains two independent transport machineries", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 281, no. 51, 2006, pages 39499 - 39506, XP008120904 * |
KARLIN; ALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 87, 1990, pages 2267 - 2268 |
LAZAROWSKI E: "Purinergic signaling in neuron-glia interactions", vol. 276, 2006, WILEY, pages: 73 - 90 |
MAYINGER P; BANKAITIS VA; MEYER DI., J CELL BIOL., vol. 131, 1995, pages 1377 - 1386 |
MORIYAMA Y ET AL., J. BIOL. CHEM., vol. 266, 1991, pages 22141 - 22146 |
MORIYAMA Y.: "Membrane energization by proton pumps is important for compartmentalization of drugs and toxins: a new type of active transport", THE JOURNAL OF EXPERIMENTAL BIOLOGY, vol. 199, 1996, pages 1447 - 1454, XP008120906 * |
MORIYAMA Y; YAMAMOTO A, J. BIOL. CHEM., vol. 270, 1995, pages 22314 - 22320 |
MORIYAMA, Y.; NELSON, N, J. BIOL. CHEM., vol. 263, 1988, pages 8521 - 8527 |
NELSON N; CIDON S; MORIYAMA Y., METHOD ENZYMOL, vol. 157, 1988, pages 619 - 633 |
OKAYAMA ET AL., MOL. CELL BIOL., vol. 5, pages 1136 |
PEARSON; LIPMAN, PROC. NATL. ACAD. SCI. USA, vol. 85, no. 8, 1988, pages 2444 - 2448 |
POUWELS ET AL.: "Cloning Vectors: A Laboratory Manual", 1985, ELSEVIER, N.Y. |
PUGLIELLI L; MANDON EC; HIRSCHBERG CB., J BIOL. CHEM., vol. 274, 1999, pages 12665 - 12669 |
SAKATA K. ET AL.: "Cloning of a lymphatic peptide/histidne transporter", BIOCHEMICAL JOURNAL, vol. 356, 2001, pages 53 - 60, XP008120905 * |
SAMBROOK ET AL.: "Molecular Cloning: A Laboratory Manual", 1989, COLD SPRING HARBOR LABORATORY |
SAMBROOK J ET AL.: "Molecular Cloning: A Laboratory Manual", 1987, COLD SPRING HARBOR LABORATORY PRESS |
SAMBROOK J. ET AL.: "Molecular Cloning: A Laboratory Manual", 2001, COLD SPRING HARBOR |
See also references of EP2159281A4 |
SHABAROVA, Z. ET AL., ADVANCED ORGANIC CHEMISTRY OF NUCLEIC ACIDS, 1994 |
SNINSKY, J.J. ET AL.: "PCR Applications: Protocols for Functional Genomics", 1999, ACADEMIC PRESS |
SUGGS ET AL.: "Developmental Biology Using Purified Genes", 1981, pages: 683 |
THOMAS ET AL., CELL, vol. 51, 1987, pages 503 |
THOMPSON ET AL., NUCLEIC ACIDS RES., vol. 22, no. 2, 1994, pages 4673 - 4680 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017126700A1 (ja) * | 2016-01-20 | 2017-07-27 | 芳則 森山 | 小胞型ヌクレオチドトランスポーター活性阻害剤 |
CN116803424A (zh) * | 2023-08-24 | 2023-09-26 | 上海懿贝瑞生物医药科技有限公司 | Slc17a5基因抑制剂及其用途 |
CN116803424B (zh) * | 2023-08-24 | 2023-11-28 | 上海懿贝瑞生物医药科技有限公司 | Slc17a5基因抑制剂及其用途 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2008126517A1 (ja) | 2010-07-22 |
EP2159281A1 (en) | 2010-03-03 |
EP2159281A4 (en) | 2010-12-15 |
EP2159281B1 (en) | 2012-09-26 |
US7951595B2 (en) | 2011-05-31 |
US20100167411A1 (en) | 2010-07-01 |
JP5219146B2 (ja) | 2013-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE531383T1 (de) | Therapeutische verwendung eines wachstumsfaktors, metrnl | |
WO2009009587A3 (en) | Apoptosis-modulating protein therapy for proliferative disorders and nanoparticles containing the same | |
WO2007143098A3 (en) | Hepatocyte growth factor (hgf) binding proteins | |
GB2436508B (en) | Method for production of radioisotope preparations and their use in life science,research,medical application and industry | |
WO2007090569A8 (de) | Konditionierte blutzusammensetzung und verfahren zu deren herstellung | |
WO2009017655A3 (en) | Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance p or an analog thereof | |
WO2008046003A3 (en) | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases | |
WO2010017196A3 (en) | Monoclonal antibodies against tissue factor pathway inhibitor (tfpi) | |
WO2006088888A3 (en) | Aptamer therapeutics useful in the treatment of complement-related disorders | |
WO2005112981A3 (en) | Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells | |
MX2009006685A (es) | Antagonistas del dr6 y usos de los mismos en el tratamiento de trastornos neurologicos. | |
EP2465923A3 (en) | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions | |
WO2009013461A8 (en) | Growth hormone fusion proteins | |
WO2006096640A3 (en) | Use of neuronal precursor cells for treatment of central nervous system lesions | |
WO2006009765A3 (en) | Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells | |
WO2008157791A3 (en) | Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones | |
WO2006138714A3 (en) | Naphthyridine compounds | |
WO2008076954A3 (en) | Heterocycle compounds and methods of use thereof | |
MX2009012969A (es) | Grelina no acilada como agente terapeutico en el tratamiento de trastornos metabolicos. | |
ATE512133T1 (de) | 1h-pyrrol-2-carbonsäureamide und imidazol-5- carbonsäureamide und deren verwendung als fak-, kdr- und tie2-kinase-modulatoren zur behandlung von krebs | |
WO2008147483A8 (en) | Neurogenic compounds | |
WO2009106819A3 (en) | Biological materials and uses thereof | |
IL186228A0 (en) | Preparation of autologous haematopoietic stem cells, the methods of production, cryopreservation and use for therapy of traumatic diseases of the central nervous system | |
WO2007035722A8 (en) | Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration | |
ATE549017T1 (de) | Verwendung von tranilast und seinen derivaten zur behandlung von neurologischen zuständen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2008526701 Country of ref document: JP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08721298 Country of ref document: EP Kind code of ref document: A1 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008721298 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12594149 Country of ref document: US |